{"id":29140,"date":"2026-02-07T19:31:40","date_gmt":"2026-02-07T19:31:40","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/cell-based-immunotherapy-market-mordor\/"},"modified":"2026-09-11T16:51:08","modified_gmt":"2026-09-11T07:51:08","slug":"cell-based-immunotherapy-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/cell-based-immunotherapy-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc138\ud3ec \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026\ub144 &#8211; 2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cell-based-immunotherapy-market-1750331355574-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cell-based-immunotherapy-market-size-image-1767904835760.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc554 \uc720\ubcd1\ub960 \uae09\uc99d \ubc0f \uc870\uae30 \uce58\ub8cc \uc2b9\uc778<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc720\uc804\uc790 \ud3b8\uc9d1 \ubc0f \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uacf5\ud559\uc758 \uae09\uc18d\ud55c \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc0c1\uc5c5\uc6a9 CAR-T \ucd9c\uc2dc\ub97c \uc704\ud55c \ud655\uc7a5\ub418\ub294 \uc0c1\ud658 \ud504\ub808\uc784\uc6cc\ud06c<\/li>\n<li class=\"toc-level-3\">4.2.4 \ub300\ud615 \uc81c\uc57d\uc0ac\uc758 M&amp;A, \ub77c\uc774\uc120\uc2f1 \uacc4\uc57d \ubc0f \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.5 \ud604\uc7a5 \uc9c4\ub8cc \ub9c8\uc774\ud06c\ub85c \uacf5\uc7a5\uc744 \ud1b5\ud55c \uc815\ub9e5-\uc815\ub9e5 \uc21c\ud658 \uc2dc\uac04 \ub2e8\ucd95<\/li>\n<li class=\"toc-level-3\">4.2.6 \ub9bc\ud504\uad6c \uace0\uac08\uc744 \uc81c\uac70\ud558\ub294 \uc0dd\uccb4 \ub0b4 CAR \ud398\uc774\ub85c\ub4dc \uc804\ub2ec \ud50c\ub7ab\ud3fc<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ubcf5\uc7a1\ud558\uace0 \ucde8\uc57d\ud55c \uacf5\uae09\ub9dd \ubc0f \uc804\ubb38 \uc778\ub825 \ubd80\uc871<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70(CRS) \uc704\ud5d8 \ubc0f \uad00\ub828 \ucc45\uc784 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.3 \uaddc\ubaa8 \ud655\uc7a5\uc744 \uc81c\uc57d\ud558\ub294 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc6d0\ub8cc \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc0dd\uccb4 \ub0b4 \uc720\uc804\uc790 \uc804\ub2ec \ubca1\ud130\uc5d0 \ub300\ud55c \uaddc\uc81c \ubd88\ud655\uc2e4\uc131<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.6 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.6.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc138\ud3ec \uacf5\uae09\uc6d0\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc790\uac00\uc720\ub798<\/li>\n<li class=\"toc-level-3\">5.1.2 \ub3d9\uc885\uc720\ub798<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc138\ud3ec \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 CAR-T \uc138\ud3ec<\/li>\n<li class=\"toc-level-3\">5.2.2 TCR-T \uc138\ud3ec<\/li>\n<li class=\"toc-level-3\">5.2.3 CAR-NK \uc138\ud3ec<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc885\uc591\uce68\uc724\ub9bc\ud504\uad6c (TIL)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc8fc\uc694 \uc801\uc751\uc99d\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 B\uc138\ud3ec \uc545\uc131\uc885\uc591<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc804\ub9bd\uc120\uc554<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc2e0\uc7a5\uc138\ud3ec\uc554<\/li>\n<li class=\"toc-level-3\">5.3.4 \uac04\uc554<\/li>\n<li class=\"toc-level-3\">5.3.5 \uae30\ud0c0 \uc801\uc751\uc99d<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubcd1\uc6d0<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc804\ubb38 \uc554 \uc13c\ud130<\/li>\n<li class=\"toc-level-3\">5.4.3 \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Adaptimmune Therapeutics plc<\/li>\n<li class=\"toc-level-3\">6.3.2 Allogene Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.3 Atara Biotherapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.4 Autolus Therapeutics plc<\/li>\n<li class=\"toc-level-3\">6.3.5 Bluebird Bio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.6 Bristol Myers Squibb Co.<\/li>\n<li class=\"toc-level-3\">6.3.7 Cabaletta Bio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.8 Caribou Biosciences Inc.<\/li>\n<li class=\"toc-level-3\">6.3.9 Celyad Oncology SA<\/li>\n<li class=\"toc-level-3\">6.3.10 F. Hoffmann-La Roche Ltd<\/li>\n<li class=\"toc-level-3\">6.3.11 Gamida Cell Ltd<\/li>\n<li class=\"toc-level-3\">6.3.12 Gilead Sciences Inc.<\/li>\n<li class=\"toc-level-3\">6.3.13 Johnson &amp; Johnson<\/li>\n<li class=\"toc-level-3\">6.3.14 JW Therapeutics Co. Ltd<\/li>\n<li class=\"toc-level-3\">6.3.15 Legend Biotech Corp.<\/li>\n<li class=\"toc-level-3\">6.3.16 Lonza Group Ltd<\/li>\n<li class=\"toc-level-3\">6.3.17 Miltenyi Biotec B.V. &amp; Co. KG<\/li>\n<li class=\"toc-level-3\">6.3.18 Mustang Bio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.19 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.20 Orca Bio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.21 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.22 Precision BioSciences Inc.<\/li>\n<li class=\"toc-level-3\">6.3.23 Sorrento Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.24 Tessa Therapeutics Ltd<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc138\ud3ec \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5 \uac1c\uc694: \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc138\ud3ec \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc758 \uaddc\ubaa8, \uc810\uc720\uc728, \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uc608\uce21\uc744 \uc0c1\uc138\ud788 \ubd84\uc11d\ud569\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 2026\ub144 56\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 107\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud558\uc5ec, \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 13.83%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc744 \ud615\uc131\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ubd84\uc11d \ubc0f \uc8fc\uc694 \ub3d9\ud5a5<br \/>\n\uc138\ud3ec \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc\ub294 \uce58\ub8cc \ubc94\uc704 \ud655\uc7a5, \uc0c1\ud658 \ud504\ub808\uc784\uc6cc\ud06c \ud655\ub300, \ub300\ud615 \uc81c\uc57d\uc0ac\uc758 \uc0dd\uc0b0 \ub2a5\ub825 \ud655\ucda9\uc5d0 \ud798\uc785\uc5b4 \ucd08\uae30 \uad6c\uc81c \uce58\ub8cc \uc635\uc158\uc5d0\uc11c \ud45c\uc900 \uce58\ub8cc\ubc95\uc73c\ub85c \ube60\ub974\uac8c \uc804\ud658\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc790\uac00\uc720\ub798(Autologous) \uce58\ub8cc\ubc95\uc774 \uc5ec\uc804\ud788 \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\uc9c0\ub9cc, CRISPR \uc720\uc804\uc790 \ud3b8\uc9d1 \uae30\uc220\ub85c \uc774\uc2dd\ud3b8\ub300\uc219\uc8fc\ubcd1(GvHD) \uc704\ud5d8\uc744 \uc904\uc774\uace0 \uc81c\uc870 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud55c \ub3d9\uc885\uc720\ub798(Allogeneic) \ud504\ub85c\uadf8\ub7a8\uc774 \uae09\uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc720\uc804\uc790 \ud3b8\uc9d1, \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uacf5\ud559, \ud604\uc7a5 \uc0dd\uc0b0 \ub9c8\uc774\ud06c\ub85c \ud329\ud1a0\ub9ac \ub4f1 \uae30\uc220 \uc735\ud569\uc740 \uce58\ub8cc \uc8fc\uae30\ub97c \ub2e8\ucd95\uc2dc\ud0a4\uace0 \uc788\uc73c\uba70,\uc774\ub294 \ud658\uc790 \uc811\uadfc\uc131\uc744 \ub192\uc774\uace0 \ube44\uc6a9 \ud6a8\uc728\uc131\uc744 \uac1c\uc120\ud558\ub294 \ub370 \uae30\uc5ec\ud569\ub2c8\ub2e4. \ub610\ud55c, \uc778\uacf5\uc9c0\ub2a5(AI)\uacfc \uba38\uc2e0\ub7ec\ub2dd(ML) \uae30\uc220\uc740 \uce58\ub8cc\uc81c \uac1c\ubc1c \ubc0f \ud658\uc790 \ub9de\ucda4\ud615 \uce58\ub8cc \uc804\ub7b5 \uc218\ub9bd\uc5d0 \ud601\uc2e0\uc744 \uac00\uc838\uc624\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uae30\uc220 \ubc1c\uc804\uc740 \uc138\ud3ec \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \ub354\uc6b1 \uac00\uc18d\ud654\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc138\ubd84\ud654<br \/>\n\uc2dc\uc7a5\uc740 \uce58\ub8cc \uc720\ud615(\uc790\uac00\uc720\ub798, \ub3d9\uc885\uc720\ub798), \uc801\uc751\uc99d(\ud608\uc561\uc554, \uace0\ud615\uc554, \uc790\uac00\uba74\uc5ed\uc9c8\ud658 \ub4f1), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ubcd1\uc6d0, \uc554 \uc13c\ud130, \uc5f0\uad6c \uae30\uad00) \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub429\ub2c8\ub2e4. \ud608\uc561\uc554\uc740 \ud604\uc7ac \uac00\uc7a5 \ud070 \uc801\uc751\uc99d \ubd80\ubb38\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc9c0\ub9cc, \uace0\ud615\uc554 \uce58\ub8cc\ub97c \uc704\ud55c \uc5f0\uad6c \uac1c\ubc1c\uc774 \ud65c\ubc1c\ud788 \uc9c4\ud589\ub418\uba74\uc11c \ud5a5\ud6c4 \uace0\ud615\uc554 \ubd80\ubb38\uc758 \uc131\uc7a5\uc774 \ub450\ub4dc\ub7ec\uc9c8 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<br \/>\n\uc138\ud3ec \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc740 \uc18c\uc218\uc758 \ub300\ud615 \uc81c\uc57d\uc0ac\uc640 \ub2e4\uc218\uc758 \ud601\uc2e0\uc801\uc778 \ubc14\uc774\uc624\ud14d \uae30\uc5c5\ub4e4\uc774 \uacbd\uc7c1\ud558\ub294 \uad6c\uc870\uc785\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc740 \uc5f0\uad6c \uac1c\ubc1c \ud22c\uc790 \ud655\ub300, \uc804\ub7b5\uc801 \uc81c\ud734 \ubc0f \uc778\uc218 \ud569\ubcd1\uc744 \ud1b5\ud574 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, \ub3d9\uc885\uc720\ub798 \uce58\ub8cc\ubc95 \uac1c\ubc1c\uc5d0 \ub300\ud55c \uacbd\uc7c1\uc774 \uce58\uc5f4\ud558\uba70, \uc774\ub294 \ub354 \ub113\uc740 \ud658\uc790\uad70\uc5d0 \ub300\ud55c \uc811\uadfc\uc131\uc744 \uc81c\uacf5\ud558\uace0 \uc81c\uc870 \ubcf5\uc7a1\uc131\uc744 \uc904\uc77c \uc218 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uaddc\uc81c \uc2b9\uc778 \ubc0f \uc784\uc0c1 \uc2dc\ud5d8 \uacb0\uacfc\ub294 \uc2dc\uc7a5 \uacbd\uc7c1\ub825\uc5d0 \uacb0\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc138\ud3ec \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc774 \uc2dc\uc7a5\uc740 \uc885\uc591 \ubc0f \uba74\uc5ed \uc9c8\ud658 \uce58\ub8cc\ub97c \uc704\ud574 T\uc138\ud3ec, NK\uc138\ud3ec, \uc218\uc9c0\uc0c1\uc138\ud3ec \ub4f1 \uc0b4\uc544\uc788\ub294 \uba74\uc5ed\uc138\ud3ec\ub97c \ubd84\ub9ac, \uc870\uc791, \uc99d\uc2dd \ubc0f \uc7ac\uc8fc\uc785\ud558\ub294 \uce58\ub8cc\ubc95\uc744 \uc758\ubbf8\ud569\ub2c8\ub2e4. CAR-T, TCR-T, TIL, CAR-NK \ubc0f \uc218\uc9c0\uc0c1\uc138\ud3ec \ubc31\uc2e0\uacfc \uac19\uc740 \uc0c1\uc5c5\ud654\ub418\uc5c8\uac70\ub098 \ud6c4\uae30 \uc784\uc0c1 \ub2e8\uacc4\uc5d0 \uc788\ub294 \uc81c\ud488\ub4e4\uc774 \uc8fc\uc694 \uc218\uc775\uc6d0\uc744 \uad6c\uc131\ud558\uba70, \ud56d\uccb4, \uc800\ubd84\uc790 \ud654\ud569\ubb3c, \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c\ub294 \ubc94\uc704\uc5d0\uc11c \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd\uc5d0 \ub530\ub974\uba74, 2026\ub144 56.4\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc600\ub358 \uc138\ud3ec \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 13.83% \uc131\uc7a5\ud558\uc5ec 107.8\uc5b5 \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \uc554 \uc720\ubcd1\ub960 \uc99d\uac00 \ubc0f \uc870\uae30 \uce58\ub8cc \uc2b9\uc778 \ud655\ub300, \uc720\uc804\uc790 \ud3b8\uc9d1 \ubc0f \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uacf5\ud559\uc758 \uae09\uc18d\ud55c \ubc1c\uc804, CAR-T \uce58\ub8cc\uc81c \uc0c1\uc5c5\ud654\ub97c \uc704\ud55c \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300, \ube45\ud30c\ub9c8\uc758 M&#038;A, \ub77c\uc774\uc120\uc2f1 \uacc4\uc57d \ubc0f \uc0dd\uc0b0 \ub2a5\ub825 \ud655\ucda9, \ud608\uc561 \ucc44\ucde8\ubd80\ud130 \uc7ac\uc8fc\uc785\uae4c\uc9c0\uc758 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\ub294 \ud604\uc7a5 \uc9c4\ub8cc \ub9c8\uc774\ud06c\ub85c \ud329\ud1a0\ub9ac \ub3c4\uc785, \ub9bc\ud504\uad6c \uc81c\uac70 \uacfc\uc815\uc744 \uc5c6\uc560\ub294 \uc0dd\uccb4 \ub0b4 CAR \ud398\uc774\ub85c\ub4dc \uc804\ub2ec \ud50c\ub7ab\ud3fc \uac1c\ubc1c \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \ubcf5\uc7a1\ud558\uace0 \ucde8\uc57d\ud55c \uacf5\uae09\ub9dd \ubc0f \uc804\ubb38 \uc778\ub825 \ubd80\uc871, \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70(CRS) \uc704\ud5d8 \ubc0f \uad00\ub828 \ucc45\uc784 \ube44\uc6a9, \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc6d0\ub8cc \ubb3c\uc9c8 \ubcd1\ubaa9 \ud604\uc0c1\uc73c\ub85c \uc778\ud55c \uc0dd\uc0b0 \uaddc\ubaa8 \ud655\ub300 \uc81c\uc57d, \uc0dd\uccb4 \ub0b4 \uc720\uc804\uc790 \uc804\ub2ec \ubca1\ud130\uc5d0 \ub300\ud55c \uaddc\uc81c \ubd88\ud655\uc2e4\uc131 \ub4f1\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \ud2b9\ud788, \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc6d0\ub8cc \ubb3c\uc9c8 \ubd80\uc871\uacfc GMP \uad50\uc721\uc744 \ubc1b\uc740 \uacfc\ud559\uc790 \ubd80\uc871\uc740 \ub2e8\uae30\uc801\uc778 \uc0dd\uc0b0 \uaddc\ubaa8 \ud655\ub300\ub97c \uc81c\uc57d\ud558\uc5ec \uc0b0\uc5c5 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uc57d 1.1% \uac10\uc18c\uc2dc\ud0a4\ub294 \uc8fc\uc694 \ubcd1\ubaa9 \ud604\uc0c1\uc73c\ub85c \uc9c0\ubaa9\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc740 \uc138\ud3ec \uacf5\uae09\uc6d0(\uc790\uac00\uc720\ub798, \ub3d9\uc885\uc720\ub798), \uc138\ud3ec \uc720\ud615(CAR-T, TCR-T, CAR-NK, TIL), \uc8fc\uc694 \uc801\uc751\uc99d(B\uc138\ud3ec \uc545\uc131\uc885\uc591, \uc804\ub9bd\uc120\uc554, \uc2e0\uc7a5\uc554, \uac04\uc554 \ub4f1), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ubcd1\uc6d0, \uc804\ubb38 \uc554 \uc13c\ud130, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00), \uadf8\ub9ac\uace0 \uc9c0\uc5ed\ubcc4(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4.<\/p>\n<p>2025\ub144 \uae30\uc900 \uc790\uac00\uc720\ub798 \uc138\ud3ec \uacf5\uae09\uc6d0\uc774 Kymriah, Yescarta, Breyanzi, Carvykti\uc640 \uac19\uc740 \uc0c1\uc5c5\ud654\ub41c \uc81c\ud488\uc758 \uc131\uc219\ub3c4\uc5d0 \ud798\uc785\uc5b4 \uc2dc\uc7a5 \uc810\uc720\uc728 72.31%\ub85c \uc9c0\ubc30\uc801\uc778 \uc704\uce58\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uae30\uc220 \ud50c\ub7ab\ud3fc\uc740 CAR-NK \ud504\ub85c\uadf8\ub7a8\uc73c\ub85c, HLA \ub9e4\uce6d\uc774\ub098 \ub9bc\ud504\uad6c \uc81c\uac70 \uc5c6\uc774 \uc989\uc2dc \ud22c\uc5ec \uac00\ub2a5\ud55c \uc7a5\uc810\uc73c\ub85c \uc778\ud574 \uc5f0\ud3c9\uade0 15.07%\uc758 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc911\uad6d\uacfc \uc77c\ubcf8\uc758 \uc2e0\uc18d\ud55c \uaddc\uc81c \uc2b9\uc778 \ubc0f \uc11c\uad6c\uad8c \ub300\ube44 \ub0ae\uc740 \ud604\uc9c0 \uac00\uaca9\uc5d0 \ud798\uc785\uc5b4 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uc5f0\ud3c9\uade0 16.21%\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\ub294 Adaptimmune Therapeutics, Allogene Therapeutics, Bristol Myers Squibb, Gilead Sciences, Novartis, Pfizer \ub4f1 \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uacfc \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc810\uc720\uc728 \ubd84\uc11d\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc885\uc591 \uc804\ubb38\uc758, \uc138\ud3ec \uce58\ub8cc\uc81c \uc81c\uc870 \ucc45\uc784\uc790, \ubcd1\uc6d0 \uc57d\uad6d \uad6c\ub9e4\uc790 \ub4f1\uacfc\uc758 \uc2ec\uce35 \uc778\ud130\ubdf0\ub97c \ud1b5\ud55c 1\ucc28 \uc5f0\uad6c\uc640 FDA, EMA \uc2b9\uc778 \uae30\ub85d, WHO \uc554 \ubc1c\uc0dd\ub960 \ub370\uc774\ud130, NIH \uc784\uc0c1\uc2dc\ud5d8 \ub4f1\ub85d\ubd80 \ub4f1 \uacf5\uac1c \ub370\uc774\ud130 \ubc0f \uc720\ub8cc \ub77c\uc774\ube0c\ub7ec\ub9ac\ub97c \ud65c\uc6a9\ud55c 2\ucc28 \uc5f0\uad6c\ub97c \uae30\ubc18\uc73c\ub85c \ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8\ub294 \uc9c8\ubcd1 \ubc1c\uc0dd\ub960, \uc801\uaca9\uc131 \uc810\uc720\uc728, \uce58\ub8cc\uc81c \ucc44\ud0dd\ub960\uc5d0\uc11c \ud30c\uc0dd\ub41c \ud658\uc790 \ucf54\ud638\ud2b8\ub97c \uc9c0\uc5ed\ubcc4 \uac00\uc911 \ud3c9\uade0 \ud310\ub9e4 \uac00\uaca9(ASP)\uc73c\ub85c \uc0b0\uc815\ud558\ub294 \ud558\ud5a5\uc2dd \ubaa8\ub378\uacfc \uacf5\uae09\uc5c5\uccb4 \uc1a1\uc7a5 \uc0d8\ud50c \ubc0f \uc0dd\uc0b0 \ub2a5\ub825 \uac10\uc0ac\ub97c \ud1b5\ud55c \uc0c1\ud5a5\uc2dd \uac80\uc99d\uc744 \ud1b5\ud574 \uc608\uce21\ub418\uc5c8\uc2b5\ub2c8\ub2e4. Mordor Intelligence\uc758 \ubd84\uc11d\uc740 \uc5c4\uaca9\ud55c \ubc94\uc704 \uc124\uc815, \ubcf4\uc218\uc801\uc778 ASP \uace1\uc120 \uc801\uc6a9, \uc5f0\uac04 \uc5c5\ub370\uc774\ud2b8 \uc8fc\uae30\ub97c \ud1b5\ud574 \ud22c\uba85\ud558\uace0 \uc2e0\ub8b0\ud560 \uc218 \uc788\ub294 \ub370\uc774\ud130\ub97c \uc81c\uacf5\ud558\uba70, \uc804\ub7b5\uc801 \uc758\uc0ac\uacb0\uc815\uc744 \uc704\ud55c \uacac\uace0\ud55c \uae30\uc900\uc810\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \ubbf8\ucda9\uc871 \uc218\uc694\ub97c \ud574\uacb0\ud558\uace0 \ubbf8\ub798 \uc131\uc7a5 \uae30\ud68c\ub97c \ubaa8\uc0c9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-29140","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/29140"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=29140"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/29140\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=29140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=29140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=29140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}